Covance has named Raymond Kaiser, Ph.D., global science leader and vice president for biotechnology services. Kaiser will replace Dr. Carl Martin, who will be retiring from this role, after 35 years with Covance.
Kaiser comes to Covance from Merck Research Laboratories where he was executive director of bioprocess research and development. Over a 21-year career in the biopharmaceutical industry, he has published more than 50 papers and received patents on various aspects of the development, manufacture and characterization of biologics and vaccines.
“Covance has been providing high-quality, comprehensive biotechnology services globally for more than 20 years,” said John Robson, vice president and general manager, global early development. “Adding Ray — a recognized thought leader in the industry — to the Covance team will help us continue to enhance our service offering and to make significant contributions to biological development.”